Stocktoria

Viskase Holdings, Inc. ENZN

OTC · stock · Biological Products, (No Diagnostic Substances) · website · IPO 1984-02-16 · LEI

Viskase Holdings, Inc. statistics & valuation

P / B0.5×
Net debt$132.6M
Enterprise value USD$204.1M
Earnings yield EBIT/EV-2.6%
Return on capital-2.8%

Market cap as of 2026-06-30. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
2016201720182019202020212022202320242025
Operating margin (%)
-470.00% -2509.60% -66.90% -3969.20% -5103.80% 2016201720182019202020212022202320242025
Return on equity (%)
-10.90% 59.50% 39.00% -16.20% -17.80% -9.60% -5.50% 0.50% -2.30% 2016201720182019202020212022202320242025
Shares outstanding
44.2M 44.2M 44.2M 44.2M 74.2M 74.2M 74.2M 74.2M 74.2M 74.2M 2016201720182019202020212022202320242025
Net debt ($)
$132.6M 2016201720182019202020212022202320242025
Share buybacks ($)
2016201720182019202020212022202320242025
Return on assets (%)
-10.00% 57.20% 37.70% -15.10% -2.70% -1.00% -0.40% 2.90% 1.60% -0.80% 2016201720182019202020212022202320242025
Free cash flow margin (%)
2016201720182019202020212022202320242025
Debt / equity (×)
0.97× 2016201720182019202020212022202320242025
EPS ($)
-$0.03 $0.12 -$0.03 -$0.03 -$0.02 $0.00 -$0.01 -$0.07 2016201720182019202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating margin—-5103.8%—-3969.2%-66.9%-2509.6%-470.0%———
Net margin—2992.3%—-715.4%-66.9%-2521.2%-472.9%84.5%65.0%-13.4%
Return on assets-0.8%1.6%2.9%-0.4%-1.0%-2.7%-15.1%37.7%57.2%-10.0%
Return on equity-2.3%0.5%-39.2%-5.5%-9.6%-17.8%-16.2%39.0%59.5%-10.9%
Debt / equity0.97×—————————
Current ratio0.9728.1027.6227.89118.50117.0714.1728.1220.588.41

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.